- Home
- UBSI vs BLTE Comparison
UBSI vs BLTE Comparison
Compare UBSI & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBSI | BLTE |
|---|---|---|
| Founded | 1982 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.2B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | UBSI | BLTE |
|---|---|---|
| Price | $45.15 | $138.13 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $43.17 | ★ $198.00 |
| AVG Volume (30 Days) | ★ 686.2K | 206.5K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ 18.91 | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $311,957,000.00 | N/A |
| Revenue This Year | $10.13 | N/A |
| Revenue Next Year | $5.36 | $492.11 |
| P/E Ratio | $50.43 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $34.10 | $56.68 |
| 52 Week High | $45.93 | $200.00 |
Technical Indicators
Market Signals| Indicator | UBSI | BLTE |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 42.74 |
| Support Level | $43.10 | $130.00 |
| Resistance Level | $45.93 | $168.44 |
| Average True Range (ATR) | 0.73 | 8.76 |
| MACD | 0.21 | 0.27 |
| Stochastic Oscillator | 94.81 | 39.01 |
Price Performance
Historical ComparisonAbout UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which offers a full range-of-products and services through various delivery channels. Included among the banking products and services offered are the acceptance of deposits in checking, savings, time, and money market accounts; the making and servicing of personal, credit card, commercial, and floor plan loans; and the making of construction and real estate loans, as well as the origination and sale of residential mortgages in the secondary market. Also offered are trust and brokerage services, safe deposit boxes, and wire transfers.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.